Emily Hinchcliff

Assistant Professor of Gynecologic Oncology at Northwestern Medicine. The views expressed here are my own.

[NM Obstetrics and Gynecology @NM_ObGyn]

Robert H. Lurie Comprehensive Cancer Center at Northwestern University and the Northwestern Medicine Division of Gynecologic Oncology are hosting Survive and Thrive on Friday, September 29. This program shares the latest advances in cancer therapies, survivorship and supportive care methodology. In addition, patients and caregivers can engage with experts in gynecologic cancer.

Register now: https://t.co/k0mcvM1IF5

[Nicole D. Fleming MD @nicoleflemingmd]

Our @MDAndersonNews Gyn Onc Felix Rutledge Society dinner @SGO_org #SGOMtg #sgo2023 #oncsurgery

[Emily Hinchcliff @HinchcliffEmily]

What an awesome hands-on skills session at the @SGO_org Allied Health meeting. So great to get to help out, and also get to see friends in the process! #sgomtg @LurieCancer @MDAndersonNews @DrKMills

[Emily Hinchcliff @HinchcliffEmily]

Honored to open the endometrial cancer updates session! Excellent further updates now ongoing from @DarioRoqueMD and Dr Alok Pant

[Jenna Marcus @JMarcusMD]

@HinchcliffEmily making science interesting and teaching us about molecular classification in endometrial cancer. #NMsurviveandthrive2022 #gyncancer #endometrialcancer #NMGynOnc

[Jenna Marcus @JMarcusMD]

Dr. Siobhan Phillips teaching us all about getting healthy and staying physically active. #NMsurviveandthrive2022 #NMGynOnc #sitlessandmovemore

[Lurie Cancer Center @LurieCancer]

Looking forward to tomorrow’s Survive & Thrive program for people with #gynecologiccancer — past or present — and those at increased risk, along with their families & caregivers. View the list of experts and the topics they’ll discuss: https://t.co/TFQqvuQka7

[Emily Hinchcliff @HinchcliffEmily]

@KDRichardson924 @LurieCancer @DarioRoqueMD Can’t wait to say hi! (#honored)

[Lurie Cancer Center @LurieCancer]

Join us Fri. Oct. 7 for an interactive discussion with our experts! Women with #gynecologiccancer-past or present-as well as those at increased risk, families & caregivers, are invited to register. Check out the details at: https://t.co/BLgXi35ilQ #gyncsm

[Emily Hinchcliff @HinchcliffEmily]

Such a great discussion during the @NM_ObGyn @NU_ObGynRes summer series about social media in professional development! Honored to weigh in next to all 🌟s @drevefeinberg @AngChaudhariMD

[UT MD Anderson @UTMDAnderson]

MD Anderson is grateful to CPRIT for providing $2.5 million to support expansion of cervical cancer prevention services to rural and medically underserved populations.

https://t.co/cUZI6jKVu2

@CPRITTexas @KMSchmeler #EndCancer

[Deborah W. Bruner @DeborahWBruner1]

COMING TO A THEATER (ok, not a theater but @NRGonc member hospital) NEAR YOU! PHIII trial of sentinel lymph node mapping on lower limb dysfunction in uterine #Cancer. Plan on PREMIER this FALL. #NRG2022

[Emily Hinchcliff @HinchcliffEmily]

🌟All-star graduating fellow @AllisonSaizMD presents @NU_ObGynRes research day: @SGO_org provider reported patterns re: surgical management of early cervical cancer. Controversy remains in practice! @edtanner @EmmaBarberMD @daroque22 @JMarcusMD @matei_dem

[Northwestern Ob/Gyn Residency @NU_ObGynRes]

We are so excited to be celebrating our Annual Resident and Fellow Research Day in person this year after 2 long years!

[Karen Lu @karenluMD]

Congrats to ⁦@LaurenPCobb⁩ for her #ASCO22 abstract on use of non-chemo regimen for neoadjuvant tx of advanced low grade #ovarian cancer! Exceptional responses in hard to treat disease ⁦@AmirJazaeri⁩ ⁦@RareOvarCancers⁩ #oncsurgery ⁦@MDAndersonNews⁩

[Emily Hinchcliff @HinchcliffEmily]

Honored to present these results! Providing the foundation for exciting mechanistic work and trial options @AmirJazaeri @MDAndersonNews

[Ali Saiz, MD MS @AllisonSaizMD]

@HinchcliffEmily on clear cell #OvarianCancer: PPP2R1A mutations consistently assoc w/ improved survival when treating with immune checkpoint inhibitors + may be a prognostic biomarker and possible target (drug/trial option coming soon!)
#SGOMtg

[Laurence Bernard @laubernard]

Incredible findings from
@MDAndersonNews
at #SGO2022. PPP2R1A mutation in platinum-resistant ovarian clear cell carcinoma predicts exceptional survival when treated with CTLA-4 and PD-1 checkpoint inhibitors.

@HinchcliffEmily @AmirJazaeri
#SGOmtg

[@GynOncJnls @gynoncjnls]

Assoc Editor Gyn Onc @RauhHainMD describes important components of #database #studies @gynoncjnls @SGO_org #SGO2022 #Evaluecalculator

[Aaron Shafer @aaronshafer99]

⁦Our fellow Deanna Glassman presenting her innovative and novel AI model to help predict response to therapy in HGSOC. So proud! #SGOmtg ⁦⁦@AnilSoodMD⁩ @karenluMD⁩ ⁦@maonstad⁩ ⁦⁦@Frumovitz⁩

[Karen Lu @karenluMD]

Deanna Glassman giving an awesome @SGO plenary talk on strategy of overcoming bevacizumab resistance with glutaminase inhibitor for ovarian cancer!!! Congrats to her and mentor ⁦@AnilSoodMD⁩ !! #oncsurgery #SGOmtg ⁦@MDAndersonNews⁩

[Emily Hinchcliff @HinchcliffEmily]

#NRG2022: excellent science, mentorship, and the opportunity to call out/congratulate your friends for being social media influencers @katiekurnit @BeccaPrevisMD @GOG @NRGonc #internationalwomeninscienceday